Clinical Trial Update: BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating BCMA-directed CAR-T cell therapy in adults with multiple myeloma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA-directed CAR-T cell therapy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED